Ajit Dash

2.2k total citations · 1 hit paper
38 papers, 1.8k citations indexed

About

Ajit Dash is a scholar working on Immunology, Hepatology and Epidemiology. According to data from OpenAlex, Ajit Dash has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 11 papers in Hepatology and 9 papers in Epidemiology. Recurrent topics in Ajit Dash's work include Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and IL-33, ST2, and ILC Pathways (6 papers). Ajit Dash is often cited by papers focused on Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and IL-33, ST2, and ILC Pathways (6 papers). Ajit Dash collaborates with scholars based in United States, United Kingdom and Germany. Ajit Dash's co-authors include Mark B. Pepys, Brian R. Wamhoff, M B Pepys, E. A. Munn, A. Feinstein, Ryan E. Feaver, Aviva Petrie, Thelma C. Fletcher, Banumathi K. Cole and Neil Richardson and has published in prestigious journals such as Nature, The Lancet and The Journal of Immunology.

In The Last Decade

Ajit Dash

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial

2021 195 citations Steven G. Kelsen, Ioana Agache et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ajit Dash United States	21	486	360	360	350	301	38	1.8k
Christina Wu United States	26	736 1.5×	174 0.5×	561 1.6×	268 0.8×	222 0.7×	64	2.0k
G P Jahreis United States	21	796 1.6×	228 0.6×	482 1.3×	298 0.9×	252 0.8×	29	2.0k
Steven D. Carson United States	30	965 2.0×	119 0.3×	406 1.1×	243 0.7×	431 1.4×	96	2.9k
Christophe Desterke France	27	881 1.8×	123 0.3×	270 0.8×	589 1.7×	409 1.4×	138	2.6k
Takanori Sakaguchi Japan	28	748 1.5×	129 0.4×	348 1.0×	314 0.9×	890 3.0×	125	2.6k
Jan Heidemann Germany	29	751 1.5×	113 0.3×	763 2.1×	448 1.3×	544 1.8×	65	2.5k
Cathal Harmon Ireland	15	461 0.9×	152 0.4×	823 2.3×	374 1.1×	170 0.6×	21	1.8k
Владимир Субботин United States	35	1.0k 2.1×	204 0.6×	951 2.6×	499 1.4×	1.1k 3.7×	108	3.4k
Pedro Majano Spain	31	734 1.5×	152 0.4×	361 1.0×	1.1k 3.1×	446 1.5×	59	2.8k
Susumu Miyata Japan	20	890 1.8×	145 0.4×	431 1.2×	196 0.6×	247 0.8×	29	2.2k

Countries citing papers authored by Ajit Dash

Since Specialization

Citations

This map shows the geographic impact of Ajit Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajit Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajit Dash more than expected).

Fields of papers citing papers by Ajit Dash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajit Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajit Dash. The network helps show where Ajit Dash may publish in the future.

Co-authorship network of co-authors of Ajit Dash

This figure shows the co-authorship network connecting the top 25 collaborators of Ajit Dash. A scholar is included among the top collaborators of Ajit Dash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajit Dash. Ajit Dash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Wenhui, Dorothy Cheung, Alice Fong, et al.. (2025). Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti‐ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies. Clinical and Translational Science. 18(10). e70338–e70338.

Kelsen, Steven G., Marcus Maurer, Michael R. Waters, et al.. (2025). Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Respiratory Research. 26(1). 302–302.

Yoshida, Kenta, et al.. (2024). Simulation‐based evaluation of personalized dosing approaches for anti‐FGFR/KLB bispecific antibody fazpilodemab. CPT Pharmacometrics & Systems Pharmacology. 13(4). 544–550. 4 indexed citations

Zhang, Wenhui, Dorothy Cheung, Alice Fong, et al.. (2024). Pharmacokinetics (PK) of the anti-ST2 monoclonal antibody, astegolimab. PA2987–PA2987. 2 indexed citations

Mansfield, John, Annemarie Lekkerkerker, Yehong Wang, et al.. (2023). Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis. Gut. 72(8). 1451–1461. 13 indexed citations

Maurer, Marcus, Dorothy Cheung, Xiaoying Yang, et al.. (2022). Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis. Journal of Allergy and Clinical Immunology. 150(6). 1517–1524. 43 indexed citations

Dash, Ajit, Jill Fredrickson, Nicholas Lewin‐Koh, et al.. (2022). Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial. Hepatology. 78(3). 847–862. 24 indexed citations

Kelsen, Steven G., Ioana Agache, Weily Soong, et al.. (2021). Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. Journal of Allergy and Clinical Immunology. 148(3). 790–798. 195 indexed citations breakdown →

Treem, William R., Melissa Palmer, Isabelle Lonjon‐Domanec, et al.. (2020). Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Safety. 44(2). 133–165. 24 indexed citations

10.

Dash, Ajit, Robert A. Figler, Svetlana Marukian, et al.. (2016). Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicology in Vitro. 39. 93–103. 29 indexed citations

11.

Chapman, Kimberly A., Maria Sol Collado, Robert A. Figler, et al.. (2015). Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytes. Molecular Genetics and Metabolism. 117(3). 355–362. 13 indexed citations

12.

Terelius, Ylva, Robert A. Figler, Svetlana Marukian, et al.. (2015). Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chemico-Biological Interactions. 255. 31–44. 27 indexed citations

13.

Dash, Ajit, Michael B. Simmers, Tye Deering, et al.. (2013). Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. American Journal of Physiology-Cell Physiology. 304(11). C1053–C1063. 91 indexed citations

14.

Dash, Ajit, Brett R. Blackman, & Brian R. Wamhoff. (2012). Organotypic systems in drug metabolism and toxicity: challenges and opportunities. Expert Opinion on Drug Metabolism & Toxicology. 8(8). 999–1014. 16 indexed citations

15.

Domanský, Karel, et al.. (2009). Perfused multiwell plate for 3D liver tissue engineering. Lab on a Chip. 10(1). 51–58. 8 indexed citations

16.

Dash, Ajit, W. R. Inman, Keith Hoffmaster, et al.. (2009). Liver tissue engineering in the evaluation of drug safety. Expert Opinion on Drug Metabolism & Toxicology. 5(10). 1159–1174. 127 indexed citations

17.

Pepys, Mark B., et al.. (1978). Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(1). 119–24. 166 indexed citations

18.

Pepys, M B, Ajit Dash, & M. J. Ashley. (1977). Isolation of C-reactive protein by affinity chromatography.. PubMed. 30(1). 32–7. 73 indexed citations

19.

Pepys, Mark B., et al.. (1977). Isolation and study of murine C3.. PubMed. 33(4). 491–9. 31 indexed citations

20.

Pepys, Mark B., Mark Wansbrough‐Jones, Ajit Dash, et al.. (1976). Complement in the Induction of IgA and IgE Antibody Production. The Journal of Immunology. 116(6). 1746–1746. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact